MARKET

BIOL

BIOL

BIOLASE
NASDAQ

Real-time Quotes | Nasdaq Last Sale

0.4888
-0.0142
-2.82%
After Hours: 0.4701 -0.0187 -3.83% 17:53 05/27 EDT
OPEN
0.5000
PREV CLOSE
0.5030
HIGH
0.5099
LOW
0.4700
VOLUME
1.11M
TURNOVER
--
52 WEEK HIGH
2.073
52 WEEK LOW
0.2110
MARKET CAP
15.52M
P/E (TTM)
-0.6597
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 3 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average BIOL stock price target is 2.383 with a high estimate of 3.500 and a low estimate of 1.650.

EPS

BIOL News

More
Edited Transcript of BIOL earnings conference call or presentation 7-May-20 8:30pm GMT
Thomson Reuters StreetEvents · 2d ago
Analysts Have Just Cut Their BIOLASE, Inc. (NASDAQ:BIOL) Revenue Estimates By 11%
Simply Wall St. · 05/19 11:31
BIOLASE Inc (BIOL) CEO Todd Norbe on Q1 2020 Results - Earnings Call Transcript
Seeking Alpha - Transcript · 05/10 21:35
BIOLASE, Inc. (NASDAQ:BIOL) First-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For This Year
Simply Wall St. · 05/10 13:36
Biolase Q1 EPS $(0.190) Misses $(0.140) Estimate, Sales $4.700M Miss $4.980M Estimate
Biolase (NASDAQ:BIOL) reported quarterly losses of $(0.190) per share which missed the analyst consensus estimate of $(0.140) by 35.71 percent. This is a 26.67 percent decrease over losses of $(0.150) per share from the
Benzinga · 05/07 20:21
As others cave, several public companies that took small business loans are not giving back the cash
Six companies contacted by CNBC who took the loans said they had no plans to return small business and PPP funds.
CNBC.com · 04/24 17:01
Edited Transcript of BIOL earnings conference call or presentation 26-Mar-20 8:30pm GMT
Thomson Reuters StreetEvents · 04/16 15:35
Mid-Afternoon Market Update: Dow Surges 400 Points; Crude Oil Down 6%
Toward the end of trading Thursday, the Dow traded up 1.71% to 23,834 while the NASDAQ rose 0.76% to 8,152.28. The S&P also rose, gaining 1.59% to 2,793.57.
Benzinga · 04/09 18:34

Industry

Advanced Medical Equipment & Technology
+0.72%
Healthcare Equipment & Supplies
+0.73%

Hot Stocks

Symbol
Price
%Change

About BIOL

BIOLASE, Inc. (BIOLASE) is a medical device company that develops, manufactures, markets and sells laser systems in dentistry and medicine. The Company markets, sells, and distributes dental imaging equipment, including cone beam digital x-rays and computer-aided design (CAD)/computer-aided manufacturing (CAM) intra-oral scanners, in-office, chair-side milling machines and three-dimensional (3-D) printers. It offers two categories of laser system products: WaterLase (all-tissue) systems and Diode (soft tissue) systems. Its brand, WaterLase, uses a combination of water and laser energy to perform procedures performed using drills, scalpels, and other traditional dental instruments for cutting soft and hard tissue. It also offers its Diode laser systems to perform soft tissue, pain therapy, and cosmetic procedures, including teeth whitening. Its Waterlase and Diode systems use disposable laser tips of differing sizes and shapes depending on the procedures being performed.
More

Webull offers kinds of BIOLASE Inc stock information, including NASDAQ:BIOL real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BIOL stock news, and many more online research tools to help you make informed decisions.